The DSC2 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for the disruption of the DSC2 gene, encoding desmocollin-2. This polyclonal format provides a heterogeneous pool of edited cells, enabling robust loss-of-function studies without the clonal selection bias inherent in monoclonal lines. The knockout strategy leverages CRISPR/Cas9 to introduce target gene disruption across the cell population, generating a versatile model for investigating DSC2-dependent processes in an epithelial context.
The host cell line, HEK293T, is a widely utilized human embryonic kidney epithelial derivative that constitutively expresses the SV40 large T-antigen. This cell line is valued for its high transfection efficiency and robust protein expression capabilities, routinely employed in viral packaging and recombinant protein production. Its epithelial origin provides a relevant backdrop for studying cell-cell adhesion mechanisms and desmosomal biology, as HEK293T cells retain fundamental junctional protein expression profiles that allow functional interrogation of cadherin-mediated adhesion.
Desmocollin-2, the protein product of DSC2, is a calcium-dependent desmosomal cadherin essential for mediating strong intercellular adhesion in tissues such as the epidermis and myocardium. DSC2 functions within the desmosome complex by interacting with armadillo proteins plakoglobin (JUP) and plakophilins (PKP1?C3), and recruiting desmoplakin (DSP) to link intermediate filaments to the plasma membrane. Upstream, DSC2 expression is regulated by the p63 transcription factor, GATA3, Wnt ligands, and extracellular calcium concentration.
Downstream, DSC2 promotes desmoplakin recruitment and plakoglobin stabilization, thereby anchoring keratin intermediate filaments and forming desmosomal plaques. Disruption of DSC2 abolishes these interactions, impairing desmosome assembly and potentially altering Wnt/??-catenin signaling through redistribution of plakoglobin. In the HEK293T background, DSC2 knockout eliminates desmocollin-2 protein, leading to weakened intercellular adhesion and compromised epithelial barrier integrity.
This model recapitulates key aspects of desmosome dysfunction observed in diseases such as arrhythmogenic right ventricular cardiomyopathy, autosomal recessive hypotrichosis, and cancer metastasis. The loss of DSC2 in these cells allows researchers to dissect the molecular consequences of desmosomal disruption, including effects on cell migration, invasion, and apoptosis, providing a tractable in vitro system for studying epithelial adhesion signaling. This knockout cell population supports a wide range of applications, including desmosome biology studies, cardiomyopathy disease modeling, epithelial barrier integrity assays, drug screening for junction-targeting therapies, and cancer metastasis research. Representative experimental approaches include western blotting to confirm DSC2 ablation, immunofluorescence for junctional proteins such as DSP and JUP, cell adhesion and migration/invasion assays, co-immunoprecipitation of desmosomal complexes, and apoptosis or drug sensitivity testing. For further information, please contact Ascent Research.
